Decibel Therapeutics, Inc. Profile Avatar - Palmy Investing

Decibel Therapeutics, Inc.

Decibel Therapeutics, Inc., a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders. Its product candidates and programs focuses on three areas, such as Gene Therapies for …

Biotechnology
US, Boston [HQ]
Strategy & Leadership

Mergers & Acquisitions Beta

M&A Deals · Breakdown

Decibel Therapeutics, Inc. has no acquisition track records yet.

M&A Deals · History

Decibel Therapeutics, Inc. has no acquisition track records yet.

End of DBTX's Analysis
CIK: 1656536 CUSIP: 24343R106 ISIN: US24343R1068 LEI: - UEI: -
Secondary Listings
DBTX has no secondary listings inside our databases.